EYPT icon

EyePoint Pharmaceuticals
EYPT

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$39
163% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
RBC Capital
RBC Capital
Lisa Walter
100% 1-yr EYPT win rate
6 Nov ‘25 25 days ago